Benevir Biopharm, Inc.
- UEI
- E4ZAQPYJLJB9
- CAGE
- 6BZY7
- Primary NAICS
- 541711 Research and Development in Biotechnology
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| R & d medical: biomedical | National Cancer Institute | $199,904 | |
| Avirulent CD8+ t-cell evading oncolytic HSV-1 for the treatment of bladder cancer | National Institutes of Health | $222,694 |
Quick answers
What is Benevir Biopharm, Inc.'s UEI?
Benevir Biopharm, Inc.'s Unique Entity ID (UEI) in SAM.gov is E4ZAQPYJLJB9.
What is Benevir Biopharm, Inc.'s CAGE code?
Benevir Biopharm, Inc.'s CAGE code is 6BZY7.
What is Benevir Biopharm, Inc.'s primary NAICS code?
Benevir Biopharm, Inc.'s primary NAICS code is 541711 (Research and Development in Biotechnology).
Is Benevir Biopharm, Inc. registered in SAM.gov?
Benevir Biopharm, Inc.'s SAM.gov registration expired on August 29, 2016.
What is Benevir Biopharm, Inc.'s most recent federal award?
Benevir Biopharm, Inc.'s most recent federal contract award is R & d medical: biomedical (HHSN261201200061C), from National Cancer Institute, on September 14, 2012.
On GovTribe
See Benevir Biopharm, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors